CERRX, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cerrx.com
Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas
- First Posted Date
- 2015-07-13
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- CerRx, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT02495415
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸Baylor University Medical Center, Dallas, Texas, United States
🇺🇸Norton Healthcare, Louisville, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath